Bibliography

Bianchi, C. (2021), “Cadena de valor biofarmacéutica: potencialidades y desafíos para Uruguay: informe final”, Economic

Commission for Latin America and the Caribbean (ECLAC)/United Nations Resident Coordinator Office in Uruguay/

United Nations Industrial Development Organization (UNIDO), unpublished. Cid Pedraza, C. (2020), “Financing of integrated health service networks”, Pan American Journal of Public Health, vol. 44, September. Cid Pedraza, C. and others (2021), “Objetivos de Desarrollo Sostenible: impacto de la falta de protección financiera en salud en países de América latina y el Caribe”, Pan American Journal of Public Health, vol. 45, unpublished. (2020), “How much do countries spend on primary care in the Americas”, Tracking Resources for Primary Health Care,

World Scientific Series in Global Health Economics and Public Policy, vol. 8, H. Wang and P. Berman (eds.). Cuadrado, C. and others (2019), “National Health Insurance: a conceptual framework from conflicting typologies”, Health

Policy, vol. 123, No. 7, May. DNP (National Planning Department) (2004), Farmacéutica y medicamentos, Bogotá [online] https://colaboracion.dnp.gov. co/cdt/desarrollo%20empresarial/farmaceuticos.pdf. ECLAC (Economic Commission for Latin America and the Caribbean) (2020), “La salud como desafío productivo y tecnológico: capacidades locales y autonomía sanitaria en la Argentina pospandemia”, Project Documents (LC/TS.2020/172;

LC/BUE/TS.2020/2), Santiago. ECLAC/PAHO (Economic Commission for Latin America and the Caribbean/Pan American Health Organization) (2020),

“Health and the economy: A convergence needed to address COVID-19 and retake the path of sustainable development in Latin America and the Caribbean”, COVID-19 Report - ECLAC-PAHO, Santiago, July. EFPIA (European Federation of Pharmaceutical Industries and Associations) (2021), The Pharmaceutical Industry in Figures 2021: Key Data, Brussels [online] https://www.efpia.eu/media/602709/the-pharmaceutical-industry-in-figures-2021.pdf. El Financiero (2018), “9 de cada 10 medicinas que se venden en México son genéricas”, 24 April [online] https://www. elfinanciero.com.mx/empresas/9-de-cada-10-medicinas-que-se-venden-en-mexico-son-genericas/. EvaluatePharma (2019), World Preview 2019, Outlook to 2024 [online] https://www.evaluate.com/thought-leadership/ pharma/evaluatepharma-world-preview-2019-outlook-2024. Gleeson, D. and others (2019), “Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts”, Globalization and Health, vol. 15, No. 78. Grabois Gadelha, C. A. (2021), “O Complexo Econômico-Industrial da Saúde 4.0: por uma visão integrada do desenvolvimento econômico, social e ambiental”, Cadernos do Desenvolvimento, vol. 16, No. 28, International Celso Furtado Center for

Development Policies. Interfarma (Research-based Pharmaceutical Manufacturers Association) (2020), Guia 2020 Interfarma, April [online] https:// www.interfarma.org.br/app/uploads/2020/12/2020_VD_JAN.pdf. Malerba, F. and L. Orsenigo (2015), “The evolution of the pharmaceutical industry”, Business History, vol. 57, No. 5. Massuda, A. and others (2018), “The Brazilian health system at crossroads: progress, crisis and resilience”, BMJ Glob

Health, vol. 3, No. 4. Mathauer, I. and others (2020), “Pooling financial resources for universal health coverage: options for reform”, Bull World

Health Organ, vol. 98, No. 2, February. Mazzucato, M. and G. Dosi (eds.) (2006), Knowledge Accumulation and Industry Evolution: The Case of Pharma-Biotech,

Cambridge, Cambridge University Press. OECD (Organisation for Economic Co-operation and Development) (2019), Health at a Glance 2019: OECD Indicators,

Paris, OECD Publishing. PAHO (Pan American Health Organization) (2017), “Health financing in the Americas”, Health in the Americas [online] https://www.paho.org/salud-en-las-americas-2017/uh-financing.html. (2014), “Resolution CD53.R14: Strategy for Universal Access to Health and Universal Health Coverage”, 53rd Directing

Council, 66th session of the Regional Committee of Who for the Americas, Washington, D.C. Sabignoso, M. and others (2020), “Strengthening the purchasing function through results-based financing in a federal setting: lessons from Argentina’s Programa Sumar”, Health Financing Working Paper, No. 15, Geneva, World Health

Organization (WHO). Statista (2021), “eHealth” [online] https://www.statista.com/outlook/dmo/digital-health/ehealth/worldwide [date of reference: 15 September 2021]. Superintendency of Industry and Commerce (2020), Estudios de mercado: sector farmacéutico en Colombia, Bogotá [online] https://www.sic.gov.co/sites/default/files/documentos/032021/ES-Sector-Farmaceutico-en-Colombia.pdf. WHO/World Bank (World Health Organization/World Bank) (2019), Global Monitoring Report on Financial Protection in

Health 2019, Geneva.